Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Tax-Provision" stands at 55.00 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 06/30/2024.
Daiichi Sankyo Co. Ltd.'s first quarter result of 19.94 Billion JPY for the item "Tax Provision" represents an increase of 405.77 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Daiichi Sankyo Co. Ltd.'s first quarter result of 19.94 Billion JPY for the item "Tax Provision" represents a decrease of -19.64 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Daiichi Sankyo Co. Ltd.'s first quarter result of 55.00 Billion JPY for the item "Tax Provision" represents a decrease of -8.14 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -10.91 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -10.91 Billion Japanese Yens.
The 3 year change is 49.74 Billion Japanese Yens.
The 5 year change is 47.00 Billion Japanese Yens.
The 10 year change is 50.35 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Tax Provision | 905,699,262,464.00 |
![]() | Johnson & Johnson - Tax Provision | 486,508,953,600.00 |
![]() | AbbVie Inc - Tax Provision | 399,570,305,024.00 |
![]() | Roche Holding AG - Tax Provision | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Tax Provision | 280,205,508,085.11 |